Evaxion A/S (EVAX) stock
EVAXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.78+0.01 (+0.36%)
Close on Nov 17, 2026Market cap $23.19MP/E –Yield –
Evaxion A/S operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Evaxion A/S's operating cash flow for the twelve months ending Jun 30, 2022 was -$23.79M. For fiscal 2025 it was -$6.63M. The highest annual figure on record is -$1.99M in fiscal 2018.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$6.63M | – |
| FY2024 | Dec 31, 2024 | -$12.94M | – |
| FY2023 | Dec 31, 2023 | -$17.69M | – |
| FY2022 | Dec 31, 2022 | -$25.77M | – |
| FY2021 | Dec 31, 2021 | -$21.93M | – |
| FY2020 | Dec 31, 2020 | -$12.44M | – |
| FY2019 | Dec 31, 2019 | -$7.02M | – |
| FY2018 | Dec 31, 2018 | -$1.99M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2022 | Jun 30, 2022 | -$5.19M | – |
| Q1 FY2022 | Mar 31, 2022 | -$8.19M | – |
| Q4 FY2021 | Dec 31, 2021 | -$4.12M | – |
| Q3 FY2021 | Sep 30, 2021 | -$6.30M | – |
| Q2 FY2021 | Jun 30, 2021 | -$7.49M | – |
| Q1 FY2021 | Mar 31, 2021 | -$4.04M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.42M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.77M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.30M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.95M | – |
See a number that looks wrong?